CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income/(Loss)
Balance (in shares) at Mar. 28, 2020			50,323,000
Balance at Mar. 28, 2020	$ 587,109		$ 503	$ 553,229		$ 78,512		$ (45,135)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchase plan (in shares)			22,000
Employee stock purchase plan	2,144			2,144
Exercise of stock options (in shares)			28,000
Exercise of stock options	1,193		$ 1	1,192
Issuance of restricted stock, net of cancellations (in shares)			298,000
Issuance of restricted stock, net of cancellations	0		$ 3	(3)
Share-based compensation expense	6,167			6,167
Net income	10,527					10,527
Other comprehensive income (loss)	1,429							1,429
Balance (in shares) at Jun. 27, 2020			50,671,000
Balance at Jun. 27, 2020	608,569		$ 507	562,729		89,039		(43,706)
Balance (in shares) at Mar. 28, 2020			50,323,000
Balance at Mar. 28, 2020	587,109		$ 503	553,229		78,512		(45,135)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	90,510
Balance (in shares) at Dec. 26, 2020			50,817,000
Balance at Dec. 26, 2020	719,152		$ 508	579,480		169,022		(29,858)
Balance (in shares) at Jun. 27, 2020			50,671,000
Balance at Jun. 27, 2020	608,569		$ 507	562,729		89,039		(43,706)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)			2,000
Exercise of stock options	67		$ 0	67
Issuance of restricted stock, net of cancellations (in shares)			30,000
Share-based compensation expense	5,952			5,952
Net income	48,101					48,101
Other comprehensive income (loss)	5,234							5,234
Balance (in shares) at Sep. 26, 2020			50,703,000
Balance at Sep. 26, 2020	667,923		$ 507	568,748		137,140		(38,472)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchase plan (in shares)			22,000
Employee stock purchase plan	1,868			1,868
Exercise of stock options (in shares)			50,000
Exercise of stock options	2,578			2,578
Issuance of restricted stock, net of cancellations (in shares)			42,000
Issuance of restricted stock, net of cancellations	0		$ 1	(1)
Share-based compensation expense	6,287			6,287
Net income	31,882
Other comprehensive income (loss)	8,614							8,614
Balance (in shares) at Dec. 26, 2020			50,817,000
Balance at Dec. 26, 2020	719,152		$ 508	579,480		169,022		(29,858)
Balance (in shares) at Apr. 03, 2021			50,869,000
Balance at Apr. 03, 2021	731,670	$ (60,121)	$ 509	602,727	$ (61,156)	157,981	$ 1,035	(29,547)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchase plan (in shares)			39,000
Employee stock purchase plan	2,210			2,210
Exercise of stock options (in shares)			14,000
Exercise of stock options	500		$ 0	500
Issuance of restricted stock, net of cancellations (in shares)			91,000
Issuance of restricted stock, net of cancellations	0		$ 1	(1)
Share-based compensation expense	6,828			6,828
Net income	(4,454)					(4,454)
Other comprehensive income (loss)	447							447
Balance (in shares) at Jul. 03, 2021			51,013,000
Balance at Jul. 03, 2021	677,080		$ 510	551,108		154,562		(29,100)
Balance (in shares) at Apr. 03, 2021			50,869,000
Balance at Apr. 03, 2021	731,670	$ (60,121)	$ 509	602,727	$ (61,156)	157,981	$ 1,035	(29,547)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	33,634
Other comprehensive income (loss)	198
Balance (in shares) at Jan. 01, 2022			51,111,000
Balance at Jan. 01, 2022	730,775		$ 511	566,963		192,650		(29,349)
Balance (in shares) at Jul. 03, 2021			51,013,000
Balance at Jul. 03, 2021	677,080		$ 510	551,108		154,562		(29,100)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)			28,000
Exercise of stock options	1,070		$ 1	1,069
Issuance of restricted stock, net of cancellations (in shares)			19,000
Share-based compensation expense	5,979			5,979
Net income	14,856					14,856
Other comprehensive income (loss)	(436)							(436)
Balance (in shares) at Oct. 02, 2021			51,060,000
Balance at Oct. 02, 2021	698,549		$ 511	558,156		169,418		(29,536)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchase plan (in shares)			36,000
Employee stock purchase plan	1,999			1,999
Exercise of stock options (in shares)			12,000
Exercise of stock options	353			353
Issuance of restricted stock, net of cancellations (in shares)			3,000
Share-based compensation expense	6,455			6,455
Net income	23,232					23,232
Other comprehensive income (loss)	187							187
Balance (in shares) at Jan. 01, 2022			51,111,000
Balance at Jan. 01, 2022	$ 730,775		$ 511	$ 566,963		$ 192,650		$ (29,349)